KMHO is a consultancy that specialises in the formulation and delivery of health outcomes* strategies and communications for pharmaceuticals and medical devices.
We believe that a strong health outcomes strategy is an essential element in achieving optimal pricing, reimbursement and market access.
Our approach is rigorous and robust, yet practical and creative.
We understand the needs of both the decision makers – government, Health Technology Assessment (HTA) groups, payers and healthcare providers – and you, the client.
We recognise that health outcomes data has value across functional groups (e.g. medical, marketing, communications, government relations) and believe that these opportunities should be identified when a health outcomes strategy is being developed.
KMHO appreciate that research has no value unless it is appropriately articulated and communicated, and we are highly experienced in the development of health outcomes outputs that meet external/internal customer needs (e.g. value dossiers, NICE briefing books, internal briefings, payer slide kits, manuscripts).
*Health economics and patient-reported outcomes.